Akebia Therapeutics (AKBA) EBITDA (2013 - 2026)
Akebia Therapeutics (AKBA) reported EBITDA of -$5.74 million for Q2 2026, compared with $14.41 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) EBITDA (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Akebia Therapeutics' EBITDA came in at -$13.57 million; for FY2025, it came in at $24.77 million.
- By year, EBITDA came in at -$12.97 million in FY2024, -$8.63 million in FY2023, -$43.08 million in FY2022 and -$226.53 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$55.89 million in Q4 2021 and a high of $43.49 million in Q2 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$4.37 million (Q1 2026), -$8.23 million (Q4 2025) and $4.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | -11.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -11.36 Mn |
| Jun 30, 2026 | -5.74 Mn |
| Mar 31, 2026 | -4.37 Mn |
| Dec 31, 2025 | -8.23 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 14.41 Mn |
| Mar 31, 2025 | 13.83 Mn |
| Dec 31, 2024 | -4.96 Mn |
| Sep 30, 2024 | -3.14 Mn |
| Jun 30, 2024 | 675,000.00 |
| Mar 31, 2024 | -5.56 Mn |
| Dec 31, 2023 | 10.78 Mn |
| Sep 30, 2023 | -3.64 Mn |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2023 | -16.19 Mn |
| Dec 31, 2022 | 4.55 Mn |
| Sep 30, 2022 | -40.99 Mn |
| Jun 30, 2022 | 43.49 Mn |
| Mar 31, 2022 | -50.15 Mn |
| Dec 31, 2021 | -55.89 Mn |
API Access
Akebia Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();